Leptin Levels in Papillary Thyroid Cancer

Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01659385

Acronym

LL-PTC

Enrollment

Registered

2012-08-07

Start date

2012-08-07

Completion date

2013-04-25

Last updated

2023-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leptin Levels, Thyroid Cancer, Papillary

Brief summary

The purpose of this study is to evaluate Leptin levels in females, in the setting of papillary thyroid cancer, benign thyroid nodules, and in normal females without thyroid disease.

Detailed description

There will be three groups in this study, but 2 of the groups are part of another study so will only recruit normal controls.

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

FEMALE

Age

19 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* Female * Age\>/- 19 * Not currently pregnant or lactating * Normal thyroid gland by history

Exclusion criteria

* Male Gender * Pregnancy * Lactation * Age below 19 * Abnormal thyroid gland by history * Abnormal thyroid gland by structure using ultrasound * Abnormal thyroid gland by function using TSH, Free T4

Design outcomes

Primary

Measure	Time frame	Description
evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.	During Study	Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.

Countries

United States

Outcome results